WASHINGTON, D.C. – The Trump administration’s response to the COVID-19 pandemic has been one of incompetence and inadequacy, from ignoring and downplaying the threat at the outset to its epic mismanagement and chaotic…
Read moreWASHINGTON, D.C. – A luxury hotel brand whose portfolio boasts a dozen “full-service, primarily upscale and upper-upscale hotels” is among the latest beneficiaries of the Trump Small Business Administration’s ‘Paycheck Protection Program’…
Read moreWASHINGTON, D.C. – Despite Secretary of the Treasury Mnuchin’s protestations that the Trump SBA’s Paycheck Protection Program has been fixed, Wednesday’s Securities and Exchange Commission filings reveal that at least twelve…
Read moreWatchdog Group Analysis Finds Administration Bailed Out Large Companies with ‘Financial Issues’ Long Before Coronavirus Outbreak *Read the Analysis Here* WASHINGTON, D.C. – In recent days, President Trump, Treasury Secretary Mnuchin,…
Read moreWASHINGTON, D.C. – The latest Securities and Exchange Commission filings show 40-some additional publicly traded companies secured over $125 million in SBA Paycheck Protection Program funds meant for struggling small businesses on main street, including…
Read moreWASHINGTON, D.C. – President Trump’s Cabinet is “effectively sitting on the sidelines” during the coronavirus pandemic, according to a new report from NBC News, which finds that “many…
Read moreWASHINGTON, D.C. – The April jobs report is every bit the nightmare economists predicted, with 20.5 million falling out of the workforce and the unemployment rate more than tripling to 14.7…
Read moreWASHINGTON, D.C. – The latest Securities and Exchange Commission filings show at least 20 more publicly traded companies secured over $64 million in PPP funds. $3.5 million alone went to Sypris Solutions Inc.,…
Read moreWashington, DC – New reporting from the Associated Press reveals that the Trump administration is refusing to release guidance from top health experts at the CDC to help local…
Read moreNew analysis: Gilead could price remdesivir at $1 and STILL make a profit Gilead claims $1B in total development costs for remdesivir….less than what they paid out to shareholders in…
Read moreAs the Senate Banking Committee considers the nomination of Brian Miller to be Special Inspector General for Pandemic Recovery for the U.S. Department of the Treasury, government watchdog group Accountable.US…
Read more**Read the new report HERE** Eli Lilly claim: “using all available resources” to fight coronavirus” → Eli Lilly reality: no increase in annual R&D from projections…additional $250M in revenue. Johnson…
Read more